Roche Loses First Accutane Trial, Jury Awards $2.5M

By Christine Caulfield

Law360, New York (May 29, 2007, 12:00 AM ET) -- Swiss drug maker Roche Holding AG has lost the first of hundreds of cases set for trial over its acne medication, with a jury awarding $2.5 million to an Alabama man who developed bowel disease after taking the drug.

The jury in New Jersey's Superior Court in Atlantic City found the pharmaceutical giant had failed to adequately warn users of the dangerous side effects of Accutane since the drug came on the market in 1982.

The jury also awarded the plaintiff, Andrew McCarrell, 36, an additional...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles